Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 5, 2003, Pages 1504-1512

  Albes, Johannes M ^a,c   Stöhr, Ingeborg M ^a   Kaluza, Mirko ^a   Siegemund, Annelie ^b   Schmidt, Dirk ^a   Vollandt, Rüdiger ^a   Wahlers, Thorsten ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Heart Center Brandenburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PHOSPHORYLCHOLINE; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CELL DAMAGE; CLINICAL ARTICLE; ERYTHROCYTE; EXTRACORPOREAL CIRCULATION; HEART MUSCLE REVASCULARIZATION; HUMAN; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SHED BLOOD SEPARATION; STATISTICAL ANALYSIS;

EID: 0344925046     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00958-9     Document Type: Article

References (26)

1. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery. Anesthesiology. 2002;97:215-2.
2. Kawahito K, Mohara J, Misawa Y, Fuse K. Platelet damage caused by centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins. Artif Organs. 1997;21:1105-9.
3. Weiland AP, Walker WE. Physiologic principles and clinical sequelae of cardiopulmonary bypass. Heart Lung. 1986;15:34-9.
4. Whitten CW, Hill GE, Ivy R, Greilich PE, Lipton JM. Does the duration of cardiopulmonary bypass or aortic crossclamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesth Analg. 1998;86:28-33.
5. Schonberger JP, Everts PA, Hoffmann JJ. Systemic blood activation with open and closed venous reservoirs. Ann Thorac Surg. 1995;59: 1549-55.
6. Yu K, Lamba NMK, Courtney JM. et al. Polymeric biomaterials: influence of phosphorylcholine polar groups on protein adsorption and complement activation. Int J Artif Organs. 1994;17:499-504.
7. De Somer F, Francois K, van Oeveren W, et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg. 2000;18:602-6.
8. Lavee J, Naveh N, Dinbar I, Shinfeld A, Goor DA. Prostacyclin and prostaglandin E2 mediate reduction of increased mean arterial pressure during cardiopulmonary bypass by aspiration of shed pulmonary venous blood. J Thorac Cardiovasc Surg. 1990:100:546-51.
9. Axford TC, Dearani JA, Ragno G, et al. Safety and effectiveness of reinfused shed blood after open heart surgery. Am Thorac Surg. 1994;57:615-22.
10. Veyradier A, Fressinaud E, Boyer. Neumann C, Trossaert M, Meyer D. von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system. Thromb Haemost 2000;84:727-8.
11. Goto S, Tamura N, Handa S, Arai M, Kodama K, Takayama H. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation. 2002;106:266-72.
12. Mulholland JW, Massey W, Shelton JC. Investigation and quantification of the blood trauma caused by the combined dynamic forces experienced during cardiopulmonary bypass. Perfusion, 2000;15:485-94.
13. Wright G, Sanderson JM. Cellular aggregation and trauma in cardiotomy suction systems. Thorax. 1979;34:621-8.
14. Lohrer RM, Trammer AR, Dietrich W, Hagl S, Linderkamp O. The influence of extracorporeal circulation and hemoseparation on red cell deformability and membrane proteins in coronary artery disease. J Thorac Cardiovasc Surg. 1990;99:735-40.
15. Bergman P, Belboul A, Friberg LG, al-Khajya N, Mellgren G, Roberts D. The effect of prolonged perfusion with a membrane oxygenator (PPMO) on white blood cells. Perfusion. 1994;9:35-40.
16. Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65:712-8.
17. Yilmaz M, Haznedaroglu IC, Kirazli S, Pasaoglu I. Effects of extracorporeal circulation on thrombin-antithrombin III and prothombin fragment 1 + 2 levels. Clin Appl Thromb Hemost. 2002;8:61-3.
18. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. Thorac Cardiovasc Surg. 1999;47:111-8.
19. Sinci V, Kalaycioglu S, Gunaydin S, Imren Y, Gokoz L, Soncul H, Ersoz A. Evaluation of heparin-coated circuits with full heparin dose strategy. Ann Thorac Cardiovasc Surg. 1999;5:156-63.
20. Butler J, Wurithi EW, Pathio VL, MacArthur KJD, Berg GA. Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function. Ann Thorac Surg. 2002;74:139-42.
21. Kincaid EH, Jones TJ, Stump DA, et al. Processing scavenged blood with a cell saver reduces cerebral lipid micorembolization. Ann Thorac Surg. 2000;70:1296-300.
22. Arnestadt JP, Hyllmer M, Bengston JP, Tylman M, Mollnes TE, Bengtsson A. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration. Acta Anaesthesiol Scand. 1998;42:811-5.
23. Schmidt H, Bendtzen K, Mortensen PE. The inflammatory response after autotransfusion of shed mediastinal blood. Acta Anaesthesiol Scand. 1998;42:558-64.
24. de Haan J, Schnberger J, Han J, van Oeveren W, Eijgelaar A. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993; 106:1017-23.
25. Englberger L, Kipfer B, Berdat PA, Nydegger UE, Carrel TP. Aprotinin in coronary operatior[with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response? Ann Thorac Surg. 2002;73:1897-904.
26. Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrir, olysis before cardiopulmonary bypass. Ann Thorac Surg. 1995;60:1008-14.